SNC
IBB icon

Stifel Nicolaus & Co’s iShares Biotechnology ETF IBB Stock Holding History

Stifel Nicolaus & Co’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$2.04M Buy
29,211
+7,746
+36% +$507K 0.03% 454
2013
Q2 		$1.24M Buy
+21,465
New +$1.24M 0.02% 552

Other funds holding IBB

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Stifel Nicolaus & Co's IBB Position: Q3 2013 in Review

Stifel Nicolaus & Co increased its iShares Biotechnology ETF (IBB) stake by 36% in Q3 2013, buying an estimated $507K and bringing the position to 29,211 shares worth $2.04M. The position accounts for 0.03% of the portfolio, ranked #454.

Stifel Nicolaus & Co first reported a position in IBB in Q2 2013 and has held it in 2 quarters since. 253 funds tracked by Wall St. Rank hold IBB as of Q3 2013.

  • Stifel Nicolaus & Co held 29,211 shares of iShares Biotechnology ETF worth $2.04M as of Q3 2013.
  • Stifel Nicolaus & Co bought 7,746 iShares Biotechnology ETF shares in Q3 2013, an estimated $507K.
  • iShares Biotechnology ETF made up 0.03% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #454 holding.
  • Stifel Nicolaus & Co first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 2 quarters since.
  • 253 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.